BioSpace News Archive

Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced today it has entered into an agreement with Thermo Fisher Scientific to manufacture molnupiravir, Merck’s investigational oral antiviral medicine for the treatment of COVID-19.

bioAffinity Vice President of Research David Elzi, Ph.D., will discuss how bioAffinity successfully uses RNA interference to knock down expression of two genes that results in killing cancer cells with little or no effect on normal cells at Cell Bio.

Prodol Meditec, SA, manufacturer of the Airtraq video laryngoscope and camera system, has selected Mercury Medical as their Exclusive North America Distributor partner for their state-of-the-art video laryngoscope product line effective January 1, 2022.

Tevogen Bio, a clinical stage biotechnology company, announces the appointments of Dr. Lindee Goh who leads Tapestry Networks healthcare practice and Jeffrey Feike, President and Chief Administrative Officer of Fort Loudoun Medical Center in Tennessee, to its Innovation and Public Health Advisory Council.

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce the submission of a supplemental biologics license application to the U.S. Food and Drug Administration for the Company’s intravenous push form of administration of Trogarzo®.

Legend Biotech requests that their press release NewsItemId: 20211206005107 “Legend Biotech Announces Submission of New Drug Application to Japanese Regulatory Authority for BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed or Refractory Multiple Myeloma by Janssen” be killed.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).

Centene Corporation announced that its 2022 Financial Guidance and Investor Day event, scheduled for Friday, December 10, 2021, will now be held only in a virtual format, out of an abundance of caution over the COVID-19 Omicron variant.

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical will be presenting at the upcoming Emerging Growth Conference to be held on December 8, 2021.

Revelation Biosciences Inc. (Revelation), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, today announced it has appointed Joseph A. Bellanti, M.D. to its scientific advisory board.